| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |